Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Intellipharmaceutics International Inc
TSX:IPCI

Watchlist Manager
Intellipharmaceutics International Inc Logo
Intellipharmaceutics International Inc
TSX:IPCI
Watchlist
Price: 0.08 CAD
Market Cap: CA$2.8m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

Revenue
+
3Y
-32%
5Y
-62%
10Y
-
Operating Income
+
3Y
+43%
5Y
+79%
10Y
+70%
Net Income
+
3Y
-2%
5Y
+75%
10Y
+52%

Earnings Waterfall
Intellipharmaceutics International Inc

Income Statement
Intellipharmaceutics International Inc

Rotate your device to view
Income Statement
Currency: USD
Aug-2013 Nov-2013 Feb-2014 May-2014 Aug-2014 Nov-2014 Feb-2015 May-2015 Aug-2015 Nov-2015 Feb-2016 May-2016 Aug-2016 Nov-2016 Feb-2017 May-2017 Aug-2017 Nov-2017 Feb-2018 May-2018 Aug-2018 Nov-2018 Feb-2019 May-2019 Aug-2019 Nov-2019 Feb-2020 May-2020 Aug-2020 Nov-2020 Feb-2021 May-2021 Aug-2021 Nov-2021 Feb-2022 May-2022 Aug-2022 Nov-2022 Feb-2023 May-2023 Aug-2023
Revenue
Revenue
0
N/A
2
N/A
6
+306%
8
+24%
9
+14%
9
+0%
5
-40%
5
-4%
5
-5%
4
-15%
4
-14%
3
-20%
3
-10%
2
-11%
3
+30%
4
+49%
5
+15%
6
+10%
5
-16%
3
-31%
2
-25%
2
-29%
2
+1%
2
+37%
4
+54%
3
-4%
4
+1%
3
-23%
1
-50%
1
+4%
1
-26%
1
-39%
0
-52%
0
N/A
0
N/A
0
N/A
0
+23%
0
-36%
0
+471%
1
+128%
1
+6%
Gross Profit
Cost of Revenue
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(1)
(1)
0
(1)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(1)
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
2
N/A
3
+45%
5
+85%
0
N/A
2
N/A
2
-19%
2
-14%
2
-2%
2
+45%
4
+58%
3
-4%
4
+2%
3
-23%
1
-50%
1
+4%
0
N/A
1
N/A
0
-52%
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(1)
N/A
Operating Income
Operating Expenses
(9)
(8)
(9)
(11)
(12)
(12)
(12)
(10)
(10)
(11)
(12)
(12)
(12)
(12)
(13)
(14)
(14)
(13)
(14)
(13)
(14)
(15)
(15)
(15)
(14)
(11)
(9)
(7)
(6)
(6)
(3)
(6)
(5)
(4)
(6)
(5)
(4)
(3)
(3)
(2)
(3)
Selling, General & Administrative
(3)
(3)
(3)
(3)
(4)
(4)
(4)
(4)
(4)
(4)
(3)
(3)
(3)
(4)
(4)
(4)
(4)
(3)
(3)
(4)
(4)
(3)
(4)
(4)
(5)
(4)
(3)
(3)
(2)
(2)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(0)
(0)
(1)
Research & Development
(5)
(5)
(5)
(8)
(8)
(8)
(8)
(6)
(6)
(7)
(8)
(8)
(8)
(8)
(8)
(10)
(10)
(9)
(10)
(9)
(10)
(11)
(11)
(10)
(8)
(7)
(5)
(4)
(4)
(4)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(2)
(2)
(2)
(2)
Depreciation & Amortization
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
Operating Income
(9)
N/A
(7)
+21%
(2)
+66%
(4)
-56%
(3)
+3%
(4)
-2%
(7)
-88%
(5)
+25%
(5)
-3%
(7)
-39%
(8)
-19%
(9)
-6%
(9)
-2%
(10)
-7%
(10)
+2%
(9)
+2%
(10)
-4%
(8)
+16%
(10)
-15%
(11)
-11%
(12)
-14%
(13)
-10%
(13)
0%
(13)
+6%
(10)
+20%
(8)
+22%
(6)
+25%
(5)
+20%
(4)
+5%
(5)
-4%
(2)
+62%
(5)
-188%
(5)
+1%
(4)
+17%
(5)
-31%
(5)
+8%
(4)
+14%
(3)
+34%
(2)
+17%
(1)
+51%
(3)
-123%
Pre-Tax Income
Interest Income Expense
2
(5)
(6)
(6)
(5)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
0
(0)
Non-Reccuring Items
0
0
0
0
0
0
0
0
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
0
3
0
(1)
0
0
0
0
0
0
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
0
(0)
(0)
0
0
1
1
0
0
(0)
(0)
Pre-Tax Income
(7)
N/A
(12)
-76%
(8)
+31%
(9)
-17%
(9)
+4%
(4)
+57%
(7)
-81%
(5)
+23%
(6)
-4%
(7)
-34%
(9)
-16%
(9)
-6%
(9)
-3%
(10)
-8%
(10)
+1%
(10)
+2%
(10)
-4%
(9)
+14%
(10)
-13%
(11)
-10%
(12)
-13%
(14)
-10%
(14)
0%
(13)
+6%
(11)
+19%
(8)
+23%
(7)
+18%
(6)
+15%
(3)
+44%
(3)
-8%
(3)
+25%
(3)
-35%
(6)
-67%
(5)
+8%
(6)
-17%
(5)
+18%
(4)
+19%
(3)
+29%
(2)
+18%
(2)
+33%
(3)
-101%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
(0)
0
0
0
Income from Continuing Operations
(7)
(12)
(8)
(9)
(9)
(4)
(7)
(5)
(6)
(7)
(9)
(9)
(9)
(10)
(10)
(10)
(10)
(9)
(10)
(11)
(12)
(14)
(14)
(13)
(11)
(8)
(7)
(6)
(3)
(3)
(3)
(3)
(6)
(5)
(6)
(5)
(4)
(3)
(2)
(2)
(3)
Net Income (Common)
(7)
N/A
(12)
-76%
(8)
+31%
(9)
-17%
(9)
+4%
(4)
+57%
(7)
-81%
(5)
+23%
(6)
-4%
(7)
-34%
(9)
-16%
(9)
-6%
(9)
-3%
(10)
-8%
(10)
+1%
(10)
+2%
(10)
-4%
(9)
+14%
(10)
-13%
(11)
-10%
(12)
-13%
(14)
-10%
(14)
0%
(13)
+6%
(11)
+19%
(8)
+23%
(7)
+18%
(6)
+15%
(3)
+44%
(3)
-9%
(3)
+24%
(3)
-34%
(6)
-67%
(5)
+10%
(6)
-17%
(5)
+18%
(4)
+20%
(3)
+27%
(2)
+18%
(2)
+33%
(3)
-101%
EPS (Diluted)
-3.24
N/A
-5.84
-80%
-3.37
+42%
-4.19
-24%
-3.83
+9%
-1.67
+56%
-2.95
-77%
-2.28
+23%
-2.31
-1%
-3.13
-35%
-3.54
-13%
-3.68
-4%
-3.29
+11%
-3.8
-16%
-3.33
+12%
-3.23
+3%
-3.34
-3%
-2.86
+14%
-2.88
-1%
-2.64
+8%
-2.86
-8%
-2.89
-1%
-0.68
+76%
-0.61
+10%
-0.47
+23%
-0.37
+21%
-0.28
+24%
-0.25
+11%
-0.14
+44%
-0.14
N/A
-0.11
+21%
-0.11
N/A
-0.17
-55%
-0.17
N/A
-0.19
-12%
-0.15
+21%
-0.12
+20%
-0.09
+25%
-0.07
+22%
-0.05
+29%
-0.1
-100%

See Also

Summary
IPCI intrinsic value, competitors valuation, and company profile.
DCF Valuation
IPCI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IPCI stock valuation using valuation multiples.
Wall Street Estimates
IPCI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IPCI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 315,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.